High-dose treosulfan in patients with relapsed or refractory high-grade lymphoma receiving tandem autologous blood stem cell transplantation
Open Access
- 2 August 2004
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 34 (6) , 477-483
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Myeloablative conditioning regimens for AML allografts: 30 years laterBone Marrow Transplantation, 2003
- Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin’s Lymphoma: A Comparison With Allogeneic and Autologous Transplantation—The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2003
- Allogeneic peripheral blood stem cell transplantation for high-risk non-Hodgkin's lymphomaBone Marrow Transplantation, 2003
- Effect of rituximab on peripheral blood stem cell mobilization and engraftment kinetics in non-Hodgkin's lymphoma patientsBone Marrow Transplantation, 2003
- Why aren't we performing more allografts for aggressive non-Hodgkin's lymphoma?Bone Marrow Transplantation, 2003
- Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphomaSeminars in Oncology, 2003
- BEAC or BEAM for High-dose Therapy in Patients with Non-Hodgkin's Lymphoma? A Single Centre Analysis on Toxicity and EfficacyLeukemia & Lymphoma, 2003
- Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myelomaBone Marrow Transplantation, 2001
- Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilizationBone Marrow Transplantation, 1999
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995